GP Nord, located in North-East Europe, the significant advantage is a hands-on attitude to complex issues of sourcing high-quality medicinal products from validated sources throughout the EU. It allows us to supply the demanding markets of Asia, Central America, the Caribbean, EEC, the Middle East, and central Europe. Because we operate in a wholly validated and professional supply chain, we provide the necessary confidence and assurances to both our customers and suppliers supported by certified documentation and declarations. GP Nord SIA is a pharmaceutical company formed by three childhood friends, former English Latvians in England. Initially, it followed British companies’ example, where the primary business model is the wholesale of European goods to North Africa, the Middle East, China, Central America, and the Caribbean.